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Basic virus dynamics models have been essential in understanding quantitative issues of HIV
replication.However,severalpartsofthevirallifecycleremainelusive.Oneofthemostcriticalsteps
is the start of viral transcription, which is governed by the regulatory protein trans-activator of
transcription (Tat) that induces a positive feedback loop. It has been shown that this feedback loop
can alternate between twostatesleading toa transient activationof viral transcription. Using Monte
Carlo simulations, we integrate the transactivation circuit into a new virus dynamics model having
an age-dependent transactivation rate and reversion into latency. The cycling of infected cells
betweenanactivatedandlatentstate resultsinthetypical deceleratingdecayofvirusloadfollowing
therapy.Further,wehypothesizethattheactivationoflatentlyinfectedcellsisgovernedbythebasal
transcription rate of the integrated provirus rather than the intra- or extracellular environment.
Finally,oursystemsapproachto modelingvirusdynamics offersa promisingframeworkto inferthe
extracellular dynamics of cell populations from their intracellular reaction networks.
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Introduction
Within-host virus dynamics has traditionally been investi-
gated with mathematical models that describe events happen-
ing between different compartments on the extracellular level,
i.e., the interaction between cells and virus particles. These
models have given important insight into the dynamics
of virus infections within a host (Nowak and May, 2000;
Perelson, 2002). However, critical parts of the viral life cycle
remain elusive. Speciﬁcally, it has been difﬁcult to understand
howtheintracellularkinetics ofvirus replication caninﬂuence
the extracellular virus dynamics.
In HIV, the protein trans-activator of transcription (Tat) has
been found to have a major role within an infected cell, where
it induces viral transcription through a positive feedback loop
(Karn, 1999). It was shown in experiments that the infected
cells alternate between a highly transactivated and a resting
or latent state, depending on the intracellular concentration
of the protein Tat (Box 1). Stochastic computer simulations
oftheintracellularcircuitthatwereusedtoanalyzetheprocess
of transactivation were found to agree with the experimental
results (Weinberger et al, 2005). These ﬁndings were
intriguing and it was hypothesized that the transactivation
circuit could be a critical determinant of viral latency.
The viral reservoir of latently infected cells is considered to
be one of the major barriers for eradicating HIV from an
infected patient (Lassen et al, 2004a; Han et al, 2007). In
patients on highly active antiretroviral therapy (HAART), the
pool of latently infected cells decays very slowly, and at a
decreasing rate (Finzi et al, 1999; Siliciano et al, 2003; Strain
et al, 2003). Also, low-level viremia can persist over years
(Palmer et al, 2008). Mathematical studies have investigated
the dynamics of latently infected cells in HIV but could not
decipher the mechanism of activation and reversion (Muller
et al, 2002; Kim and Perelson, 2006; Sedaghat et al, 2008). The
majority of the pool of latently infected cells consists of resting
CD4
þ Tcells (Chun et al, 1997). As HIV mainly replicates in
activated CD4
þ T cells, it is generally believed that latently
infected cells need to be activated by extracellular stimuli to
provide the right environment for viral transcription. Anti-
genicstimulationhasbeensuggestedasamechanismatwhich
latently infected cells can become activated (Gunthard et al,
2000) and the availability of cellular transcription factors,
the chromatin structure and CpG methylation are believed to
have an effect on viral transcription (Lassen et al, 2004a;
Blazkova et al, 2009). On the other hand, different forms
of viral transcripts have been found in resting CD4
þ T cells,
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tional block but is due to an insufﬁcient amount of transcripts
and regulatory proteins, such as Tat (Lassen et al, 2004b).
Together with the ﬁndings on the intracellular transactivation
circuit, this observation suggests that viral transcripts and Tat
could slowly accumulate to induce the positive feedback loop
which itself activates the infected cell and subsequently leads
to viral replication.
We apply the intracellular model of HIV transactivation as
presented in Weinberger et al (2005) to understand the
processes of viral activation and reversion into latency. In a
systems approach to modeling virus dynamics, we derive the
transition rates of these processes and infer the dynamics of
a heterogeneous population of infected cells. We ﬁnd that a
single process, the basal transcription rate of the HIV provirus,
can govern the activation from viral latency. This highlights
that the activation of latently infected cells in HIV might be
dictated, at least in part, by intrinsic viral factors rather than
through extracellular stimuli.
Results
Dynamics of transactivation and reversion into
latency
We investigate a modiﬁed version of the computational model
presented in Weinberger et al (2005) to derive stochastic
simulations for the transactivation and reversion of HIV-
infected cells (see Materials and methods). First, we strictly
simulate only the intracellular transactivation circuit, i.e., do
not take into account processes such as infected cell death or
viral replication. Time plots of representative simulations show
the individual behavior of single cells infected with HIV
(Figure 1A). Concomitantly with the increase of the regulatory
protein Tat, the concentration of the other viral proteins
breaches a threshold where we assume that the cell is able to
generate new viral particles. An infected cell can be transacti-
vated for a long time period (e.g., black lines), whereas other
cells quickly revert back into a latent state (e.g., blue lines).
Patients infected with HIV harbor, in the order of millions or
more, infected CD4
þ Tcells that are either in an activated or a
resting (latent) state (Chun et al, 1997). The turnover of the total
infected cell populationwithin a patient will be inﬂuenced by the
stochasticﬂuctuationsinsinglecells.Toinvestigatethedynamics
that arises from a large number of infected cells, we carried out
many simulations of single cells to derive the probability
distribution of transactivation (Figure 1B, red line). A small
amount of pre-integration transcripts, mRNAn (Wu, 2004), is
sufﬁcient for the early transactivation of an infected cell during
the ﬁrst 24h after integration of the provirus. As a cascade of
stochastic processes rules the event of transactivation, it is not
surprising that the probability distribution approximates a log-
normal distribution. We can also derive the probability distribu-
tion of reversion into latency, i.e., the probability at which an
activated cell that is producing viral particles will revert into a
latent state (Figure 1C, red line). Finally, latently infected cells
can get reactivated (Figure 1D, red line).
Onceweknowtheprobabilitydistributionofatransitioninto
another state, we can derive the age-dependent rate at which it
occurs (see Materials and methods). As expected, we ﬁnd that
infected cells have a high probability of being transactivated
early after infection. The age-dependent transactivation rate
peaks a few hours after infection and decreases afterwards
(Figure 1B, blue line). Once an infected cell is activated, it can
revertintoalatentstate.Thisage-dependentreversionrate,i.e.,
the reversion rate that depends on the age of the activated cell,
reaches a constant value after an initial delay (Figure 1C, blue
line). The delay is caused through the threshold that we set in
order to discriminate between activated and latent cells.
Overall, the rate at which the feedback loop is interrupted
seems to be independent of the time the cell has spent in an
activated state. Latently infected cells can get reactivated and
we also ﬁnd a constant rate of transactivation that does not
dependontheageofthelatentcell(Figure1D,blueline).Inour
simulations, the process of transactivation in latently infected
cells is indeed governed by a single process. The rate-limiting
step of the transactivation circuit is given by the basal
transcription rate of the long terminal repeat (LTR) that
determines the rate at which latent cells become activated
virus-producing cells. To test whether this behavior holds
for an extended range of basal transcription rates, we run
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Box 1 Top left: Ina newlyinfected cell, the viral RNA istranscribed into a
linear DNA provirus (orange) that is imported into the nucleus. Before
integration at a semi-random position into the host DNA, pre-integration
transcripts can be produced. Top right: Viral transcripts are then translated
into the regulatory protein trans-activator of transcription (Tat) (blue) that
gets re-imported into the nucleus where it induces a positive feedback loop
through the elevation of the proviral transcription rate (thick red arrow).
Subsequently, the cell becomes transactivated and can produce a
sufﬁcient amount of viral proteins that can give rise to new viral particles
that are budding of the cell membrane. Bottom right: The positive feedback
loop in transactivated cells can interrupt and infected cells revert into a
latent state. These cells are now subject to a low basal transcription rate
(thin red arrow) that can eventually re-activate the latently infected cells.
Bottom left: The fate of a single cell can be determined through Monte
Carlosimulationsoftheintracellulartransactivationcircuit.Repeatingmany
simulation runs for single cells results in a distribution for the occurrence of
eachtransitionfromwhichthecorrespondingratescanbedetermined.The
rates for transactivation after infection (s), reversion into latency (r) and
reactivation of latently infected cells (a) can then be applied in a
mathematical model of virus dynamics which is depicted schematically.
It should be noted that through all stages of infection, the cells can be
subjected to cell death.
Box 1 Schematic representation of the intracellular trans-
activation during the HIV replication life cycle
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and obtain a linear relation between kb and the activation rate
of latently infected cells, a (see Supplementary Figure S1). This
highlights that the basal transcription rate determines the
activation of latently infected cells, even if the rates are widely
distributed.
An age-dependent transactivation model predicts
biphasic viral load decline during antiretroviral
therapy
Afterderiving thetransitionratesbetweenthedifferent states of
an infected cell, we can test whether the turnover between
activatedandlatentcellscanaccountforthecharacteristicvirus
load decline after the initiation of antiretroviral therapy
(Perelson et al, 1997). Hence, we integrate the cycling between
activated and latent cells into a full virus dynamics model that
includes viral replication, infection and cell death. As observed
in Figure 1B, the transactivation of HIV-infected cells early after
infection follows an age-dependent rate where the age, a,i s
given as the time that has passed since infection of the cell. In a
virus dynamics model based on partial differential equations
(PDEs) (Kirschner and Webb, 1996; Nelson et al, 2004; Althaus
et al, 2009), this can be integrated as follows:
qIða;tÞ
qt
þ
qIða;tÞ
qa
¼  sðaÞIða;tÞ;
dA
dt
¼
Z 1
0
sðaÞIða;tÞda   rA þ aL   dA;
dL
dt
¼ rA   aL   mL;
ð1Þ
where I(a,t) is deﬁned as the time-density of infected cells of
age a before theyare transactivated with rate s(a) and produce
viralparticles.WeassumethatactivatedcellsAaresubjecttoa
constant reversion rate r and die at a rate d per day that is
independent of the age of the cell (Althaus et al, 2009).
Latently infected cells, L, are generated through reversion of
activated cells and can either become activated with rate a or
die with rate m. The boundary condition of the infected cells
(i.e., the infection of cells) is simply given by I(0,t). The
dynamics of free virus particles can be described by the
conventional dV/dt¼pA cV.
Using the transition rates that we derived from the
transactivation circuit (Figure 1B, C and D, blue lines), we
have run numerical simulations of the virus dynamics model
giveninEquation(1)tomodelthechronicstateoftheinfection
(Figure 2). This set-point level during chronic infection
is perturbed by the administration of antiretroviral
drugs. Our model describes the typical shoulder phase
during the ﬁrst day after the start of therapy that is
caused by the transactivation of recently infected cells I
(Figure 2, black line) into activated, virus-producing cells A
(Figure 2, blue line). During the ﬁrst week after the start of
therapy, the virus load (Figure 2, red line) declines exponen-
tially withaslopethat approximates thedeathrateofactivated
cells A. In addition, the dynamics is partly determined by the
reversion of activated cells A into latent cells L and the
reactivation of latently infected cells (Figure 2, red line). After
the ﬁrst week during treatment, the virus decay is described
by a slower second phase that is caused by the slow
reactivationofcellsinthelatentlyinfectedcellpool,accurately
describing the ﬁrst two phases of virus load decline during
antiretroviral therapy.
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Figure 1 Dynamics of transactivation and reversion into latency. (A) Representative time plots from stochastic simulation runs of three HIV-infected cells. Each color
depicts the concentration of protein P (solid lines) and protein trans-activator of transcription (Tat) (dashed lines) within one infected cell. The dotted line indicates the
thresholdoftransactivation.(B)Probability distributionandage-dependentrateoftransactivation.Asmallamountofpre-integration transcripts(mRNAn(0)¼5)resultsin
early transactivation of HIV-infected cells. (C) Probability distribution and age-dependent rate of reversion. After a time window of a few days, the transactivated cells
revert into a latent state at a constant rate (blue line). (D) Probability distribution and age-dependent rate of transactivation of latently infected cells. Reactivation of
latently infectedcells is determined by the slowest process inthe transactivation circuit (basal transcription) andtherefore occurs ata constant rate. LTR¼1 andall other
species are zero except otherwise indicated. kb¼10
 6 s
 1 for all simulations.
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a decelerating decay during prolonged
antiretroviral therapy
The basal transcription rate of the provirus depends on the
position where it is inserted into the host DNA. Generally, the
HIV provirus appears to be inserted at positions that are under
active transcription because of the free access for integration
(Schroder et al, 2002). However, experiments have shown that
the transcriptional proﬁle of HIV proviruses obeys a distribu-
tion(Jordanetal,2001),suggestingthatthebasaltranscription
rates of some proviruses are likely to be low. Because of the
linearrelation betweenbasaltranscription ratesandactivation
rates that we have shown above, this suggests that activation
rates are also heterogeneously distributed. The decelerating
decay of virus load following drug therapy has indeed been
linked to different activation rates of latently infected cells
(Strain et al, 2003, 2005). A decelerating decay can also be
found in a recent study by Chun et al (2007) and has been
suggested by mathematical modeling (Muller et al, 2002; Kim
and Perelson, 2006). It has been speculated that the decelerat-
ing decay is a result of antigenic stimulation of resting CD4
þ T
cellsthathavedifferentspeciﬁcities.Here,wehypothesizethat
the heterogeneous activation rates of latently infected cells
derive from the integration of the provirus at different sites in
the host DNA, which results in the distribution of basal
transcription rates. Once the latently infected cell pool gets
depleted during drug treatment, the activation rates of the
remaining cells shift towards low values resulting in a
decelerating decay. As this affects the long-term behavior of
the decay dynamics, we use a simpliﬁed HIV dynamics model
that does not take into account the population of recently
infected cells, i.e., we omit the integral of transactivation from
Equation (1). For the cycling between activated and latently
infected cells, we devise the following integro-differential
equations with different classes of latently infected cells, La:
dA
dt
¼
Z amax
0
aLada   rA   dA;
dLa
dt
¼ rfðaÞA   aLa   mLa:
ð2Þ
As we assume that de novo infections have stopped, activated
cells A are only generated through activation of latently
infected cells with a maximal activation rate amax. They revert
intolatentlyinfectedcellswithraterordiewithrated.Latently
infected cells of type La are generated according to a
distribution of activation rates, f(a), become activated with
rate a and die with rate m. By solving for the explicit solution
(seeMaterialsandmethods)andusingparametersvaluesfrom
the literature, we can accurately describe the decay dynamics
of the virus load (Figure 3A and B) and the latently infected
cells(Figure3C).Weobtainsimilardecaydynamicsforseveral
distributions of activation rates, f(a), as long as they decrease
and approach zero at low activation rates. Both, the
concentration of virus and of latently infected cells falls below
one copy per ml over a prolonged period of treatment, but the
virusfailstobecomeeradicatedbecausesomelatentlyinfected
cells have very low activation rates, i.e., harbor an HIV
provirus with a very low basal transcription rate.
Discussion
It is challenging to investigate how the intracellular life cycle
of a virus inﬂuences the virus dynamics within a host. Only
few attempts have been made that combine the intra- and
extracellular levels of virus dynamics so far (Haseltine et al,
2005, 2008). Further, one often assumes populations to be
homogeneous to model the dynamics of viruses and infected
cells. However, theoretical and experimental studies have
shown how intrinsic noise in single cells can give rise to
heterogeneous cell populations (McAdams and Arkin, 1997;
Elowitz et al, 2002). Here, we used a modiﬁed computational
model of the intracellular transactivation circuit of HIV
(Weinberger et al, 2005; Weinberger and Shenk, 2007) to
elucidate the events of transactivation after infection, rever-
sion into latencyand reactivation of latently infected cells. In a
systems approach to modeling virus dynamics, we show the
inﬂuence of this transactivation circuit on the virus dynamics
that is observed after the initiation of antiretroviral therapy.
Early transcription of non-integrated proviruses has been
observed in HIV-infected cells, but the biological potential of
pre-integration transcripts are unclear (Stevenson et al, 1990;
Wu and Marsh, 2003; Wu, 2004). We ﬁnd that a small amount
of pre-integration transcripts of viral RNA can be sufﬁcient to
trigger the transactivation circuit that renders an infected cell
into an activated, virus-producing cell. The cascade of the
intracellular transactivation circuit generates a delay between
the infection of a cell and the production of viral proteins that
contributes to the intracellular delay before virus production
that is observed during the ﬁrst day after antiretroviral drug
treatment.
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Figure 2 An age-dependent transactivation model predicts biphasic viral load
decline during antiretroviral therapy. Numerical simulations of the partial
differential equation (PDE) model from Equation (1) accurately describe the ﬁrst
two phases. Recently infected cells become transactivated (black line) causing
the initialshoulder phase of the viralload after treatment (redline). Thevirus load
decays proportional to the number of activated virus-producing cells (blue line).
The ﬁrst phase of decline is followed by a slower second phase, which is caused
by reactivation of latently infected cells (green line). Initially, the simulation is run
to approach an equilibrium before the number of new infections, I(0,t), is set
to zero (dotted line). Parameters are: r¼0.019 d
 1, a¼0.039 d
 1, d¼0.7 d
 1,
m¼0.0 d
 1 and p/dV¼100.
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þ T cells
harboring an HIV provirus that does not provide sufﬁcient
transcription. Our simulations show, that a low basal
transcription rate of the LTR can keep the infected cells in a
latent state. However, as soon as a few Tat molecules have
accumulated, the transactivation circuit may render a cell to
become activated. Therefore, we postulate that the activation
of latently infected cells is, at least in part, governed by the
basal transcription rate of the provirus that is inserted in the
host DNA. In contrast to previous studies, this suggests that
the turnover of the latent infected cell pool is dictated by
intrinsic viral factors, rather than extracellular stimuli such as
antigenic activation. A recent study provides supporting
evidence that Tat can indeed prime and activate peripheral
blood mononuclear cells (PBMCs) if cultured at physiological
oxygen levels (Sahaf et al, 2008). Hence, the intracellular
transactivation circuit might result in Tat levels that induce
translocation of host transcription factors which are necessary
to activate resting CD4
þ Tcells for virus production.
The mechanisms behindthe generation ofvirallatencyhave
been difﬁcult to assess so far (Lassen et al, 2004a). Li et al
(1996) proposed that HIV-infected cells have a ‘shutdown’
mechanism for virus production. Mathematical models have
incorporated the processof reversion into latency (Bucy, 1999;
Sedaghat et al, 2008) but a deﬁnite mechanism has not been
further investigated. The transient gene expression for the
transcriptional circuit in HIV that has been found by
Weinberger et al (2008) provides a model at which viral
latency could be generated. One can speculate whether
activated, virus-producing CD4
þ cells survive long enough
to revert into a latent state (Han et al, 2007). The stochastic
simulations of the intracellular transactivation circuit result in
a reversion rate of B0.019 per day. In the model that describes
the long-term behavior of the decay dynamics, the reversion
rate is determined by Equation (9) and we obtain rB0.007 per
day. As virus-producing cells follow a constant death rate
(Althaus et al, 2009), these two estimates suggest that about
1 3% of the cells becoming latent is sufﬁcient to account for
the characteristic dynamics.
We can also show, by assuming a distribution of activation
rates in latently infected cells that would arise from a
distribution of basal transcription rates, that a model with
different classes of latently infected cells fully explains the
long-term decay dynamics during drug treatment. The second
(Perelson et al, 1997), third and fourth (Palmer et al, 2008)
phase of virus decay may not just arise from different
compartments of infected cells but may reﬂect the decay
proﬁle of latently infected cells with different activation rates,
similarasitwasshowninMulleretal(2002).Incontrasttothe
gradual depletion of latently infected cells that can be
explained by a slow process such as the basal transcription
rate, another phenomenon during antiretroviral therapy, the
occurrence of transient viral ‘blips’, are unlikely to be caused
by this mechanism. As blips appear to be the result of viral
replication in a distinct sub-population of latently infected
cells,theyaremorelikelytobecausedbyamechanismsuchas
antigenic stimulation of localized T-cell populations harboring
HIV (Rong and Perelson, 2009).
If the basal transcription rate indeed determines the
activation rate of latently infected cells, then complete
eradication of the latently infected cell pool during antire-
troviral therapy is unlikely to happen, as the resting CD4
þ
T cells may persist lifelong. However, strategies for purging
the pool of latently infected cells with activating stimuli have
been proposed (Kulkosky et al, 2001; Brooks et al, 2003). Our
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Figure 3 Intracellular trans-activator of transcription (Tat) transactivation
kinetics predict a decelerating decay during prolonged antiretroviral therapy.
(A) Viral load decay within the ﬁrst 45 days. The ﬁrst phase results primarily from
the death of activated virus-producing cells, whereas the second phase is
determined by the reactivation of latently infected cells. Experimental estimates
ofthe decay rates duringthe two phasesare given bythe dashed(Perelsonet al,
1997) and dotted (Palmer et al, 2008) lines. (B) Decelerating decay during
prolonged periods of therapy approximates experimental observations (dotted
lines, Palmer et al, 2008). (C) Similarly, the pool of latently infected cells decays
andapproximatesexperimentalestimates (dashed lines,Zhang et al,1999; Finzi
etal,1999;Ramratnametal,2000;Silicianoetal,2003).Parameters used:initial
pool of activated, virus-producing cells A0¼3.1 10
7 cells (Chun et al, 1997),
initial pool of latently infected cells I0¼1.4 10
6 cells (Chun et al, 1997), death
rate of activated, virus-producing cells d¼0.7 d
 1 (Perelson et al, 1997) and for
simplicity we assume lifelong persistence of the resting CD4
þ cells, i.e., m¼0.0
d
 1 per day. In this ﬁgure, f(a) is a normal distribution with m¼0.2 and s¼0.1,
truncated at zero and renormalized.
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provirus might prove to be a new target to activate the latently
infected cells. If the basal transcription rates could be
increased with transcriptional activators, or even with the
molecule Tat, eradication of the latently infected cell pool in a
reasonable time span may become feasible.
Different host factors are likely to contribute to the nature of
viral latency in HIV, but we have shown that the properties of
the intracellular transactivation circuit can account for many
characteristics of the viral dynamics. These ﬁndings are in
contrast with a common concept that the availability of host
transcription factors determines viral latency. However, it is
unclear whether the translocation of transcription factors is
the cause or consequence of this process. Primarily, transcrip-
tion factors such as the nuclear factor NF-kB have been found
to stabilize the transactivation circuit (Burnett et al, 2009). We
can only speculate about the deﬁnite role of the basal
transcription rate and the HIV protein Tat in the generation
andmaintenance of virallatency,but recent observations have
given support that latency could indeed be an intrinsic
property of HIV (Jeeninga et al, 2008).
Materials and methods
Intracellular transactivation circuit
TosimulatethetransactivationofHIV-infectedcellsandtheirreversion
into latency, we adopt the model from Weinberger et al (2005) and
Weinberger and Shenk (2007). For some additions of the model and
parameters, we refer to the studies by Reddy and Yin (1999) and Kim
andYin(2005).Usingchemicalkinetics,thetransactivationcircuit can
be described as follows:
LTR   !
kb LTR þ mRNAn;
mRNAn   !
ke
mRNAc;
mRNAc   !
kp
P þ mRNAc;
mRNAc   !
kt Tatc þ mRNAc;
Tatc   !
ki Tatn
LTR þ Tatn Ð
kb
ku
pTEFbd;
pTEFbd Ð
ka
kd
pTEFba;
pTEFba   !
kf
LTR þ Tatn þ mRNAn;
P   !
dP ;
Tatc   !
dT ;
Tatn   !
dT ;
mRNAn   !
dR ;
mRNAc   !
dR :
ð3Þ
The promoter site of the HIV provirus consists of the LTR, which is
underthecontrolofalowbasaltranscriptionratekb.Transcriptioncan
also happen in bursts giving rise to a higher number of mRNA
molecules, i.e., LTR   !
kb LTR þ n mRNAn. However, as long as the
transcriptional bursts also occur at a low but constant rate kb, the
properties of the transactivation circuit are not affected. Messenger
RNA is transcribed in the nucleus (mRNAn) and exported into the
cytoplasm (mRNAc) at a rate ke. There protein translation takes place,
which generates the proteins for viral particle assembly, P, and at a
lower rate the regulatory protein Tatc. After it is imported into the
nucleus, Tatn binds reversibly, together with co-factors, to the LTR
resulting in the transcriptional elongation factor pTEFbd. pTEFbd can
reversibly becomeacetylated into the activated form pTEFba that leads
to a much higher transcription rate, kf, of the provirus. Messenger
RNA, Tat and proteins P have different rates of decay.
It isimportanttonote thatwe donot takeinto accountthe processes
of the HIV replication life cycle that occur before or after transactiva-
tion, such as reverse transcription or the assembly of viral particles.
Also, it has been shown that after the ﬁrst steps of transactivation, the
regulatory protein Rev will generate differently spliced transcripts that
eventually translate into structural proteins. Although these inter-
mediate processes will extend the time delay until newly produced
viral particles are released, it is unlikely that they inﬂuence the switch-
likebehaviorofthetransactivationcircuit.Therefore,wesimplydeﬁne
aninfectedcellasactivatedandvirus-producingwhentheintracellular
concentration of the viral protein P breaches a threshold of 10
3
(Figure 1A). We initialize the simulation runs of newly infected cells
with a small amount of pre-integration transcripts (Wu, 2004).
Sensitivity analysis shows that a single transcript of mRNA is rarely
sufﬁcient to induce the positive feedback loop. However, a few mRNA
transcriptsareenoughtolaunchthetransactivationcircuitinB99%of
Table I Reaction rates for the intracellular transactivation circuit of HIV
Reaction rate Value Unit References
kb: basal transcription rate f(kb)s
 1 See legend
ke: mRNA export into cytoplasm 7.2 10
 4 s
 1 (Reddy and Yin, 1999)
kp: viral protein translation 1.0 10
 2 s
 1 See legend
kt: trans-activator of transcription (Tat) translation 1.32 10
 3 s
 1 (Weinberger et al, 2005)
ki: Tat import into nucleus 5.1 10
 3 s
 1 (Kim and Yin, 2005)
kb: binding of elongation factor 1.5 10
 4 mol
 1s
 1 (Weinberger et al, 2005)
ku: dissociation of elongation factor 1.7 10
 2 s
 1 (Weinberger et al, 2005)
ka: acetylation of elongation factor 1.0 10
 3 s
 1 (Weinberger et al, 2005)
kd: deacetylation of elongation factor 1.3 10
 1 s
 1 (Weinberger et al, 2005)
kf: transactivated transcription rate 1.0 10
 1 s
 1 (Weinberger et al, 2005)
dp: degradation rate of viral protein 5.0 10
 6 s
 1 See legend
dT: degradation rate of Tat 4.3 10
 5 s
 1 (Reddy and Yin, 1999)
dR: degradation rate of mRNA 4.8 10
 5 s
 1 (Kim and Yin, 2005)
Depending on the proviral integration into the host DNA, the basal transcription rate can be given as a distribution (see Results). The translation rate and degradation
rate of the viral protein P is adjusted that the level of intracellular protein in a fully activated cell saturates around 10
4 (Figure 1A).
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transcripts to mRNAn(0)¼5. The parameters are given in Table I. For
stochastic simulations of the transactivation circuit, we make use of
the Gillespie algorithm (Gillespie, 1977). A program of the model was
written in C and can be obtained freely on request from the authors.
From probability densities to age-dependent rates
To analyze the behavior of a large population of HIV-infected cells that
are subject to stochastic processes, we carryout many simulation runs
of the transactivation circuit given in Equation (3) within a single cell.
Forexample,inthecaseoftransactivationofrecentlyinfectedcells,we
measure the time point at which the viral protein P exceeds the
threshold of 10
3 (Figure 1A). This point is deﬁned as the time of
transactivation and we repeat the simulation 10
6 times to obtain the
probability distribution of transactivation depending on the age of the
infected cell (Figure 1B, red line). Next, we derive the age-dependent
transactivation rate s(a), where a is the age of the cell after infection.
The probability that an infected cell has not yet been transactivated
until time t is given by
exp  
Z t
0
sðaÞda
2
4
3
5 ¼ 1  
Z t
0
^ sðaÞda; ð4Þ
where s ˆ(a) is the probability density function and
R t
0 ^ sðaÞda the
cumulative probability density function of transactivation. By taking
the logarithm and differentiating over t we derive the age-dependent
transactivation rate
sðaÞ¼
^ sðaÞ
1  
R t
0 ^ sðaÞda
: ð5Þ
Similarly,thereversionrateandtransactivationrateoflatentlyinfected
cells can be obtained. For numerical simulations of the PDE model
from Equation (1), we use the age-dependent transactivation rate
obtained in Figure 1B and the constant rates that are approached in
Figure 1C and 1D to solve the equations using the escalator boxcar
trainmodelformulationasdescribedinDeRooset al(1992)(available
on http://staff.science.uva.nl/~aroos/Ebt.htm).
Virus dynamics with heterogeneous activation
rates
Based on the model given in Equation (2), we derive an explicit
mathematical solution for the dynamics of virus and latently infected
cellsduringdrugtherapy.Weextendapreviousmodelby(Mulleret al,
2002) to account for the reversion of virus-producing cells into latency
and additionally assume a distribution of activation rates of latently
infected cells, f(a). For simplicity, we consider 100% drug efﬁcacy and
therefore assume that de novo infections have stopped.
First, we examine a simple case with only one class of latently
infected cells, La, with a single activation rate a. As the turnover of
activatedcellsis muchfasterthanthatof latentlyinfectedcells,wecan
make a quasi steady-state assumption:
  AðtÞ¼
aLaðtÞ
r þ d
: ð6Þ
The virus produced by activation of latently infected cells is then
given by
VLðtÞ¼
p
c
  AðtÞ¼
p
cðr þ dÞ
aLaðtÞ¼
p
cðr þ dÞ
aLð0Þe
ð ra
rþd a mÞt; ð7Þ
where p/c accounts for the virus production and clearance.
Second, we assume a distribution of latently infected cells and
deﬁne the pre-treatment steady-state as
Lað0Þ¼
rfðaÞAð0Þ
a þ m
; ð8Þ
with A(0) being the pool of activated cells. The total pool of latently
infected cells is then given by
Lð0Þ¼
Z amax
0
Lað0Þda ¼ rAð0Þ
Z amax
0
fðaÞ
a þ m
da: ð9Þ
Now, we can account for the virus production through activation of
a heterogeneous pool of latently infected cells by simply substituting
Equation (9) into Equation (7), which gives the ﬁnal solution:
VLðtÞ¼
prAð0Þe mt
cðr þ dÞ
Z amax
0
afðaÞ
a þ m
e
ð ra
rþd aÞtda: ð10Þ
Similarly, the decay of latently infected cells is given by
LðtÞ¼rAð0Þe mt
Z amax
0
fðaÞ
a þ m
e
ð ra
rþd aÞtda: ð11Þ
In addition, the initial pool of activated virus producing cells is
decaying rapidly and the virus load is given by
VAðtÞ¼
p
c
ðAð0Þ   Að0ÞÞe ðrþdÞt; ð12Þ
where   A(0) represent the cells that are activated by latently infected cells
at time 0 and therefore have been included in Equation (10). The total
concentration of virus over time is then given by V(t)¼VL(t)þVA(t).
Numerical simulations of a full model without the quasi steady-state
assumptions validate our explicit solution (results not shown).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (http://www.nature.com/msb).
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